Skip to main content

Passing through the renal clearance barrier: Toward ultrasmall sizes with stable ligands for potential clinical applications

28Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

The use of nanoparticles holds promise for medical applications, such as X-ray imaging, photothermal therapy and radiotherapy. However, the in vivo toxicity of inorganic nanoparticles raises some concern regarding undesirable side effects which prevent their further medical application. Ultrasmall sub-5.5 nm particles can pass through the barrier for renal clearance, minimizing their toxicity. In this letter we address some recent interesting work regarding in vivo toxicity and renal clearance, and discuss the possible strategy of utilizing ultrasmall nanomaterials. We propose that small hydrodynamic sized nanoclusters can achieve both nontoxic and therapeutic clinical features. © 2014 Zhang et al.

Cite

CITATION STYLE

APA

Zhang, X. D., Yang, J., Song, S. S., Long, W., Chen, J., Shen, X., … Fan, S. (2014, April 25). Passing through the renal clearance barrier: Toward ultrasmall sizes with stable ligands for potential clinical applications. International Journal of Nanomedicine. DOVE Medical Press Ltd. https://doi.org/10.2147/IJN.S64301

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free